Is clozapine antisuicidal?

References

• Appleby L. Safer services: national confidential inquiry into suicide and homicide by people with mental illness. Department of Health, London, UK (1999).
   Google Scholar
• Meltzer HY, Fatemi H. Suicide in schizophrenia: the effect of clozapine. Gun. Neuropharmacol 18(Suppl.), S18—S24 (1995).
   Google Scholar
• Nyman AK, Jonsson H. Patterns of self- destructive behaviour in schizophrenia. Acta Psychiatr Scand. 73(3), 252–262 (1986).
   Google Scholar
• Addington DE, Addington JM. Attempted suicide and depression in schizophrenia. Acta Psychiatr Scand. 85(4), 288–291 (1992).
   Google Scholar
• Modestin J, Zarro I, Waldvogel D. A study of suicide in schizophrenic inpatients. BE J: Psychiatry 160,398–401 (1992).
   PubMed Web of Science ®Google Scholar
• Axelsson R, Lagerkvist-Briggs M. Factors predicting suicide in psychotic patients. Eur. Awl?. Psychiatry Gun. Neurosd 241(5), 259–266 (1992).
   Google Scholar
• Caldwell CB, Gottesman II. Schizophrenia — a high-risk factor for suicide: clues to risk reduction. Suicide Life Threat &hay. 22(4), 479–493 (1992).
   Google Scholar
• Munro J, O'Sullivan D, Andrews C, Arana A, Mortimer A, Kerwin R. Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance. Br. PTchiatry175, 576–580 (1999).
   Google Scholar
• Kane JM, Honigfeld G, Singer J, Meltzer H. Clozapine in treatment-resistant schizophrenics. PTchopharmacol. Bull 24(1), 62–67 (1988).
   PubMedGoogle Scholar
• Meltzer HY, Okayli G. Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk—benefit assessment. Am. J: PTchiatry152(2), 183–190 (1995).
   PubMed Web of Science ®Google Scholar
• •First published hint that clozapine may be specifically antisuicidal in a mirror image design.
   Google Scholar
• Walker AM, Lanza LL, Arellano F, Rothman KJ. Mortality in current and former users of clozapine. Epidemiology 8, 671–677 (1997).
   PubMed Web of Science ®Google Scholar
• ••Very large epidemiological cohort able tolook at completed suicides confirming the strong effect of clozapine.
   Google Scholar
• Reinstein MJ, Chasonov MA, Colombo KD, Jones LE, Sonnenberg JG. Reduction in suicide inpatients with schizophrenia receiving clozapine. Gun. Drug- Invest. 22, 341–346 (2002).
   Google Scholar
• Sernyak MJ, Desai R, Stolar M, Rosenheck R. Impact of clozapine on completed suicide. Am. PTchiatry158,931–937 (2001).
   PubMed Web of Science ®Google Scholar
• Barnes RE, Kerwin RVV. Mortality and sudden death in schizophrenia. In: Cardiovascular Risk Associated with Schizophrenia and its Treatment. Camm J (Ed.). Galliard Healthcare Communications, London, UK, 7–23 (2003).
   Google Scholar
• Meltzer HY, Alphs L, Green Al eta]. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Awl?. Gen. Bychiatry60(1), 82–91 (2003).
   Google Scholar
• •• Definitive randomized, control trial confirming the superiority of clozapine over olanzapine.
   Google Scholar
• Khan A, Khan SR, Leventhal RM, Brown WA. Symptom reduction and suicide risk among patients treated with placebo in antipsychotic clinical trials; an analysis of the Food and Drug Administration database. Am. J: Psychiatry 158 (9), 1449–1454 (2001).
   PubMed Web of Science ®Google Scholar
• Beasley CM, Sayler ME, Kiesler GM eta]. The influence of pharmacotherapy on self-directed and externally-directed aggression in schizophrenia. Schizophr Res. 29,28 (1998).
   Web of Science ®Google Scholar
• Glazer WM. Formulary decisions and health economics. J: Gun. Psychiatry 59\(Suppl. 19), 23–29 (1998).
   Google Scholar
• Herings RM, Erkens JA. Increased suicide attempt rate among patients interrupting use of atypical antipsychotics. Pharmacoepidemid Drug Sal 12 (5), 423–424 (2003).
   PubMed Web of Science ®Google Scholar
• Sturkenboom MC, Picelli G, Moore N. Mortality during use of sertindole and other antipsychotics in The Netherlands and Belgium. Pharmacoepidemiol. Drug Sal 10\(Suppl. 1), S116 (2001).
   Google Scholar
• Department of Health. Saving lives: our healthier nation (Cm 4386). Stationery Office, London, UK (1999).
   Google Scholar
• Duggan A, Warner J, Knapp M, Kerwin R. Modelling the impact of clozapine on suicide in patients with treatment-resistant schizophrenia in the UK. BE J: Psychiatry 182,505–508 (2003).
   PubMed Web of Science ®Google Scholar
• •First ever modeling exercise to calculate the number of lives saved for the extended use of clozapine.
   Google Scholar
• Meltzer HY, Cola P, Way L et al. Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia. Am J: Psychiatry 150(11), 1630–1638 (1993).
   PubMed Web of Science ®Google Scholar
• Anderson C, Connelly J, Johnstone EC, Owens DG. Disabilities and circumstances of schizophrenic patients — a follow-up study. V: cause of death. BE J: Psychiatry 159\(Suppl. 13), 30–33 (1991).
   Google Scholar
• Newman SC, Bland RC. Mortality in a cohort of patients with schizophrenia: a record linkage study. Can. J: Psychiatry3 6(4), 239–245 (1991).
   Google Scholar
• Helgason L. Twenty years' follow-up of first psychiatric presentation for schizophrenia: what could have been prevented? Acta Psychiatr Scand. 81(3), 231–235 (1990).
   Google Scholar
• Mortensen PB, Juel K. Mortality and causes of death in first admitted schizophrenic patients. BE J: Psychiatry 163,183–189 (1993).
   PubMed Web of Science ®Google Scholar
• Black DW, Fisher R. Mortality in DSM-III- R schizophrenia. Schizophr Res. 7,109–116 (1992).
   PubMed Web of Science ®Google Scholar
• Tsoi WF, Wong KE. A 15-year follow-up study of Chinese schizophrenic patients. Acta Psychiatr Scand. 84(3), 217–220 (1991).
   Google Scholar